Market Trends of Veterinary Renal Diseases Industry
The Feline Segment is Expected to Hold a Dominant Market Share During the Forecast Period
Cats tend to have a higher prevalence of renal disorders due to a number of variables, such as their unique anatomy, breed vulnerability, and a higher incidence of ailments, including chronic kidney diseases. Age-related renal degeneration is prevalent in cats, and kidney issues may run in some breeds' families. In addition, cats may conceal their symptoms, which could postpone diagnosis. Among the animal types, cats have the largest percentage of veterinary renal disorders due to the combined effects of all these factors. According to the American Veterinary Medical Association (AVMA) data from 2021, cats with CKD had a disease-specific incidence range of 2% to 20%.
Government sources such as the National Institutes of Health (NIH) highlighted the advancements in veterinary medicine that improved the management of CKD in cats. Innovations in diagnostic technologies, such as blood and urine tests for early markers of kidney disease, have enhanced veterinarians' ability to detect CKD at earlier stages. Additionally, the development of specialized diets and medications designed to slow the progression of CKD has been instrumental in improving outcomes for affected cats.
Furthermore, the USDA's Animal and Plant Health Inspection Service (APHIS) in 2022 noted that the economic impact of feline renal disease is substantial, with pet owners in the United States spending an estimated USD 2 billion annually on veterinary care and treatments for CKD. This includes costs related to diagnostic tests, medications, therapeutic diets, and regular monitoring. As the pet population ages and the number of diagnosed cases of CKD rises, the demand for effective management strategies in the feline segment of the veterinary renal diseases market is expected to continue growing.
Hence, due to the abovementioned factors, the feline segment is expected to witness significant growth in the upcoming years.
Asia-Pacific is Anticipated Register a Significant CAGR During the Forecast Period
Asia-Pacific is projected to experience substantial growth in the veterinary renal diseases market. Pet owners in this area are becoming increasingly aware of the importance of maintaining their pets' overall health. East Asia, in particular, is driving technological advancements in animal health. The rising awareness of animal health and the growing pet ownership in countries like China and Japan have created an ideal environment for leading healthcare companies to expand their operations.
In recent years, India, China, and other Asia-Pacific countries have seen a rise in pet ownership, reflecting a strong interest in adopting pets. The impact of the COVID-19 pandemic on people's mental health, coupled with the shift to work-from-home arrangements, has led many individuals to seek the psychological support and companionship that pets provide. As a result, dog adoptions in countries have increased significantly. In China, pet ownership has also seen a substantial increase, particularly in urban areas. According to World Population Review 2024, as of 2023, there were around 58.1 million pet dogs and 66.5 million pet cats in the country. In addition, according to a Euromonitor International report, the pet dog population in Singapore was around 114,000 in 2023, up by almost 3% from 2019. The pet cat population hovered around 94,000 this year, a jump of almost 10% compared with 2019.
Additionally, advancements in precision management systems are enhancing animal welfare. For instance, real-time automatic video monitoring in chicken houses can identify areas of low or abnormal occupancy and detect malfunctioning feed, triggering automatic alerts for the owner. In addition, the rising adoption of artificial intelligence in drug discovery and diagnostic platforms is also transforming the market. For instance, in October 2023, Zoetis announced the launch of Vetscan Imagyst, an AI-powered diagnostic platform, in the Asia-Pacific market. This platform includes an application for AI-based urine sediment analysis, which helps in quick and accurate diagnosis of renal conditions in pets.
Therefore, owing to the factors mentioned above, the veterinary renal diseases market is anticipated to expand in Asia-Pacific during the forecast period.
